Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Integrated Research on Acute Malnutrition in Mali (IRAM-MALI)

Lead Sponsor:

International Food Policy Research Institute

Collaborating Sponsors:

UNICEF

World Vision

Conditions:

Acute Malnutrition in Childhood

Wasting

Eligibility:

All Genders

6-23 years

Phase:

NA

Brief Summary

The IRAM MALI impact evaluation uses a cluster-randomized controlled study design to assess the impact of the package of integrated interventions aimed at reducing the longitudinal prevalence of wasti...

Detailed Description

Progress in reducing the burden of child wasting is hampered by several factors. First, programmatic evidence on how to prevent wasting is limited. There is a growing body of evidence on the effective...

Eligibility Criteria

Inclusion

  • Cohort 1 (prevention cohort):
  • Inclusion criteria are:
  • 6-6.9 months of age
  • Singleton
  • The mother must live in the study area from the time of inclusion.
  • The consent of the mother or guardian
  • Exclusion criteria are :
  • Congenital malformations that make anthropometric measurements impossible.
  • Mother intends to leave the study area before January 2022.
  • Cohort 2 (treatment cohort):
  • Inclusion criteria are :
  • The child is enrolled in CMAM treatment program.
  • The child is between 6 and 23 months of age at inclusion
  • Child lives in one of the 45 health center catchment areas in the study area
  • Cohort 3 (relapse cohort):
  • Inclusion criteria are:
  • Child has been successfully treated for wasting and MAM and has been discharged from CMAM treatment program for at least three months
  • The child is between 9 and 17 months at time of measurement.
  • The child is singleton.
  • The mother must live in the study area from the time of inclusion.
  • The consent of the mother or guardian
  • Exclusion criteria are :
  • Congenital malformations that make anthropometric measurements impossible.
  • Mother intends to leave the study area before January 2022.

Exclusion

    Key Trial Info

    Start Date :

    May 6 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 15 2022

    Estimated Enrollment :

    9797 Patients enrolled

    Trial Details

    Trial ID

    NCT04872088

    Start Date

    May 6 2021

    End Date

    October 15 2022

    Last Update

    October 28 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Koutiala Health District

    Sikasso, Mali